BCYC
Bicycle Therapeutics Ltd
4.00$
+18.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 94.4% | 94.4% | 94.3% | 97.2% | 96.9% | 97.0% | 96.9% | 96.6% | 96.7% | 95.2% | 94.9% | 94.8% | |
| 89.6% | 88.4% | 83.5% | 90.9% | 89.4% | 91.9% | 89.7% | 86.7% | 84.9% | 87.5% | 85.8% | 84.1% | |
| 89.6% | 88.4% | 83.5% | 90.9% | 89.4% | 91.9% | 89.7% | 86.7% | 84.9% | 87.5% | 85.8% | 84.1% | |
| 2.7% | 4.0% | 7.1% | 4.4% | 5.8% | 3.7% | 5.2% | 7.3% | 8.8% | 5.0% | 6.3% | 7.8% | |
| – | – | 0.0% | 0.0% | -5.8% | – | – | – | – | – | – | – | |
| 4.7% | – | – | – | – | – | – | – | – | – | – | – | |
| 34.9% | 37.7% | 34.9% | 17.4% | 16.6% | 17.1% | 16.2% | 19.6% | 19.0% | 15.0% | 15.0% | 15.9% | |
| 10.9% | 11.7% | 9.0% | 6.6% | 5.7% | 7.0% | 6.5% | 9.3% | 9.1% | 7.9% | 7.5% | 7.9% | |
| 0.7% | 0.8% | 0.9% | 2.6% | 0.6% | 0.6% | 0.6% | 0.7% | 0.6% | 0.4% | 0.2% | – | |
| 1.3% | 2.2% | 1.3% | 0.7% | 0.6% | 1.7% | 1.3% | 2.2% | 1.7% | 1.3% | 0.9% | 0.9% | |
| 4.8% | 5.2% | 5.6% | 0.8% | – | – | – | – | – | – | – | – | |
| 65.1% | 62.3% | 65.1% | 82.6% | 83.4% | 82.9% | 83.8% | 80.4% | 81.0% | 85.0% | 85.0% | 84.1% | |
| -72.4% | -86.0% | -98.4% | -54.7% | -63.1% | -71.1% | -83.9% | -98.6% | -115.1% | -125.4% | -147.2% | -166.7% | |
| 6.2% | 7.1% | 7.8% | 4.9% | 6.9% | 7.2% | 7.8% | 8.3% | 9.1% | 9.7% | 10.7% | 11.5% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.